A classical m6A motif (GAACT) was found in the DUXAP9 sequence using SRAMP (an m6A modification site predictor), so we wondered whether DUXAP9 exhibited m6A modification, which could maintain its fate in renal cancer cells. Here, DUXAP9 is linked to renal carcinoma.